Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lindioil vs Protopic in Atopic Dermatitis
NCT03614221Phase 2Completed
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Jun 2019
- Primary completion
- Dec 2021
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of indigo naturalis in atopic dermatitis (AD) (2 arms), sponsored by Chang Gung Memorial Hospital. Primary endpoint: Mean percentage change in Eczema Area Severity Index at 12 weeks. Started Jun 2019; status: completed.
02
Drugs
indigo naturalis
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT03614221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03614221.